Enokizumab
Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL) -9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways[1].
Product Specifications
CAS Number
[909875-08-7]
Product Name Alternative
MEDI-528
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/enokizumab.html
Purity
99.23
Solubility
10 mM in DMSO
Smiles
[Enokizumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Oh CK, et al. Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Inflamm Allergy Drug Targets. 2011 Jun;10 (3) :180-6.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1474214-01 0.02 mg (E-Coli)
Recombinant Strongylocentrotus purpuratus 27 kDa primary mesenchyme-specific spicule protein (PM27)
Ask
View Details 
MBS1474214-02 0.1 mg (E-Coli)
Recombinant Strongylocentrotus purpuratus 27 kDa primary mesenchyme-specific spicule protein (PM27)
Ask
View Details MBS1474214-03 0.02 mg (Yeast)
Recombinant Strongylocentrotus purpuratus 27 kDa primary mesenchyme-specific spicule protein (PM27)
Ask
View Details